Drug intelligence / Profile preview

Recombinant human-like collagen silicone gel

Development stage
Unknown
Lead developer
Giant Biogene
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Recombinant human-like collagen silicone gel is a topical medical device developed by Giant Biogene (巨子生物) for the management and repair of scars, including hypertrophic scars and keloids. The formulation combines the occlusive properties of silicone gel with the biological activity of recombinant human-like collagen (HLC). Silicone gel works by creating a semi-permeable barrier that increases hydration of the stratum corneum, which in turn helps to downregulate fibroblast activity and modulate the production of pro-fibrotic cytokines like TGF-beta. The recombinant human-like collagen, produced via a proprietary synthetic biology platform, provides a biomimetic scaffold that supports skin tissue repair and healthy remodeling. This dual-action approach is designed to flatten, soften, and fade scars while improving skin texture and elasticity. It is primarily marketed in China as a Class II medical device under the Comfy and Collgene brands.

Brand names
Comfy可复美Collgene可丽金
Other names
Human-like collagen scar repair silicone gelRecombinant collagen silicone gelHLC silicone gel

Beyond the preview

Go deeper on Recombinant human-like collagen silicone gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombinant human-like collagen silicone gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call